Technical Analysis for ENLV - Enlivex Therapeutics Ltd.

Grade Last Price % Change Price Change
F 8.61 -6.92% -0.64
ENLV closed down 6.92 percent on Thursday, May 13, 2021, on 1.3 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ENLV trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -6.92%
NR7 Range Contraction -6.92%
Inside Day Range Contraction -6.92%
Down 3 Days in a Row Weakness -6.92%
Older End-of-Day Signals for ENLV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 6 hours ago
Down 1 ATR about 7 hours ago
Down 5% about 8 hours ago
Fell Below Lower Bollinger Band about 8 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatments Virotherapy Coronavirus Tumors Cytokine Cytokines Inflammatory Conditions Cytokine Release Syndrome

Is ENLV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.3999
52 Week Low 4.49
Average Volume 139,004
200-Day Moving Average 10.38
50-Day Moving Average 11.43
20-Day Moving Average 10.33
10-Day Moving Average 10.21
Average True Range 0.82
ADX 21.17
+DI 15.24
-DI 30.80
Chandelier Exit (Long, 3 ATRs ) 9.97
Chandelier Exit (Short, 3 ATRs ) 10.77
Upper Bollinger Band 11.97
Lower Bollinger Band 8.69
Percent B (%b) -0.03
BandWidth 31.71
MACD Line -0.60
MACD Signal Line -0.47
MACD Histogram -0.133
Fundamentals Value
Market Cap 115.92 Million
Num Shares 13.5 Million
EPS -1.42
Price-to-Earnings (P/E) Ratio -6.07
Price-to-Sales 0.00
Price-to-Book 4.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.17
Resistance 3 (R3) 10.24 9.79 9.91
Resistance 2 (R2) 9.79 9.39 9.76 9.82
Resistance 1 (R1) 9.20 9.15 8.98 9.13 9.74
Pivot Point 8.75 8.75 8.64 8.72 8.75
Support 1 (S1) 8.16 8.35 7.94 8.09 7.48
Support 2 (S2) 7.71 8.11 7.68 7.40
Support 3 (S3) 7.12 7.71 7.31
Support 4 (S4) 7.05